Medications for Squamous Cell Carcinoma Of The Head And Neck

4 results

  • erbitux - cetuximab solution

    (Cetuximab)
    Imclone Llc
    Erbitux treats locally or regionally advanced and recurrent or metastatic squamous cell carcinoma of the head and neck, and K-Ras wild-type, EGFR-expressing metastatic colorectal cancer. Also indicated for BRAF V600E mutation-positive metastatic colorectal cancer with encorafenib after prior therapy.
    Medication Details
    Drug Interactions

  • keytruda - pembrolizumab injection, powder, lyophilized, for solution

    (Pembrolizumab)
    Merck Sharp & Dohme Llc
    KEYTRUDA is a PD-1 blocking antibody that treats multiple cancers—including melanoma, lung, head and neck, bladder, colorectal, gastric, cervical, breast, and renal cancers—as well as MSI-H/dMMR and TMB-H solid tumors, used across neoadjuvant, adjuvant, and metastatic settings.
    Medication Details
    Drug Interactions

  • opdivo - nivolumab injection

    (Nivolumab)
    E.R. Squibb & Sons, L.L.C.
    Opdivo is a PD-1 blocking antibody indicated for multiple cancers including melanoma, non-small cell lung cancer, renal cell carcinoma, Hodgkin lymphoma, head and neck cancer, urothelial carcinoma, colorectal cancer, hepatocellular carcinoma, esophageal cancer, and gastric cancers in adults and select pediatric patients.
    Medication Details
    Drug Interactions